Actively Recruiting
Quality of Life in Acute Complicated and Chronic Recurrent Left-sided Diverticulitis
Led by Kepler University Hospital · Updated on 2026-03-18
136
Participants Needed
4
Research Sites
232 weeks
Total Duration
On this page
Sponsors
K
Kepler University Hospital
Lead Sponsor
K
Krankenhaus Barmherzige Schwestern Linz
Collaborating Sponsor
AI-Summary
What this Trial Is About
Patients presenting in hospital with symptoms of acute diverticulitis. Acute inflammation of the left-sided colon is confirmed with CT scan or ultrasound in experienced centers and diagnosis is defined according to the "Classification of Diverticular Disease (CDD)". CDD Type 2a, 2b and 3b will be included and then randomized in two groups. Group A will get an early left hemicolectomy 7 to 10 days after admission and initial antibiotic therapy and/or drainage of the abscess. Group B is designated for an elective resection 6 to 8 weeks after dismissal at the earliest and initial conservative treatment and/or after drainage of the abscess. Six weeks after the operation patients of Group A will be asked for their present quality of life with a standardized scoring system (Gastrointestinal Quality of Life Index = GIQLI; Short-form 36 Score = SF-36 Score; Low anterior resection syndrome = LARS Score). Group B (elective resection) will be asked at their readmission prior to elective surgery is done. This survey package will be repeated again 6 to 8 weeks later in both groups. Primary endpoints will be the two GIQLI at the said examination times. Secondary endpoints will be SF-36 score, LARS-score, GIQLI-Domains, anastomosis insufficiency and other complications, mortality and length of hospital stay. Comparisons between the groups are made at the said examination times but also 6-8 weeks after the operation.
CONDITIONS
Official Title
Quality of Life in Acute Complicated and Chronic Recurrent Left-sided Diverticulitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent to participate in the study
- Diagnosed with CDD Type 2a or 2b acute complicated left-sided diverticulitis
- Diagnosed with CDD Type 3b relapsing diverticulitis without complications (more than 2 episodes within 2 years)
- Acute symptoms at presentation
- Inflammation is located in the left-sided colon
- Diagnosis confirmed by CT scan or ultrasound from experienced radiologists
You will not qualify if you...
- Younger than 18 years
- Pregnant
- Body mass index over 55 kg/m2
- Current colorectal cancer in the left-sided colon
- Taking oral or intravenous corticosteroids
- Undergoing chemotherapy
- Previous left hemicolectomy surgery
- Unable to care for themselves at home or unable to follow instructions
- Not fit for surgery due to anesthesia risks or other specialist assessments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Ordensklinikum Elisabethinen Linz
Linz, Austria, Austria, 4020
Actively Recruiting
2
Krankenhaus Barmherzige Schwestern Linz
Linz, Upper Austria, Austria, 4010
Actively Recruiting
3
Kepler University Hospital
Linz, Upper Austria, Austria, 4020
Actively Recruiting
4
Universitätsklinikum Mannheim
Mannheim, Mannheim, Germany, 68167
Not Yet Recruiting
Research Team
S
Sandra Raab, Dr.
CONTACT
A
Andreas Shamiyeh, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here